Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations. (2nd July 2016)

• Record Type: Journal Article
• Authors: Tolusso, Barbara; Alivernini, Stefano; Gigante, Maria Rita; Ferraccioli, Gianfranco; Gremese, Elisa
• Is Part Of: Expert review of clinical immunology. Volume 12:Number 7(2016)
• Page Start: 751
• Page End: 762
• Publication Date: 2016-07-02
• Subjects: Rheumatoid arthritis -- adipose tissue -- inflammation -- weight loss -- adipocytokines -- myeloid cells -- treatment response; Clinical immunology -- Periodicals; 616.079
• DOI: 10.1586/1744666X.2016.1159132
• Languages: English
• ISSNs: 1744-666X

Abstract

ABSTRACT: Adipose tissue is an active organ playing a role not only in metabolism but also in immune and inflammatory processes, releasing several pro-inflammatory mediators. This can explain the possible association between obesity and rheumatoid arthritis (RA) and its role in the progression of the disease. Adipose and synovial tissues share common histological features of local inflammation in terms of activation of target tissues infiltrating cells (i.e. myeloid cells). Among the so-called adipocytokines, PEDF and Chemerin orchestrate the cellular cross-talk between adipose and myeloid cells, being possible biomarkers to monitor the effect of weight loss or the decrease of adipose tissue in patients with RA. Moreover, dietary intervention has been demonstrated to reduce Chemerin as well as IL-6 and MCP-1 expression. Finally, epigenetic regulators such as micro-RNAs (i.e. miR-155) are key regulators of myeloid cells activation in RA and obesity as well as in adipocytes. In this review, we will summarize the biological link between obesity/overweight state and RA focusing on pathophysiological mechanisms, consequences and management considerations.